Trial intelligence / Profile preview

Cohort study of cytomegalovirus retinitis treated with intravitreal ganciclovir injections in Chiang Mai University Hospital, Thailand

TCTR20130505001Recruiting

Sponsor
Francis I. Proctor Foundation
Start
Mar 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ganciclovir in cytomegalovirus chorioretinitis (CMVR), sponsored by Francis I. Proctor Foundation. Started Mar 2013; status: recruiting.

02

Drugs

ganciclovir
03

Conditions

cytomegalovirus chorioretinitis (CMVR)

Beyond the preview

Go deeper on TCTR20130505001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20130505001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call